Abbott’s Evolution From Diversified Healthcare to Med-Tech Compounder

Written by

in

Abbott Laboratories may be undergoing a business transformation that is not immediately obvious from the headline numbers, but becomes much clearer when viewed across the last decade of results. For years, Abbott has been seen as a broad healthcare conglomerate with exposure to nutrition, diagnostics, medical devices and established pharmaceuticals. That description is still technically […]

You are unauthorized to view this page.

  • Rummu provides data, analysis, and tools for research purposes only. The information presented does not constitute financial advice, a recommendation, or an offer to buy or sell any securities. It does not take into account individual objectives, financial situations, or needs. You are solely responsible for your own investment decisions.